• About
    • Our Story
    • Our Vision/Mission
    • Our Team
    • Pressroom
  • For Families
    • What is LCA?
    • ‘Let’s Chat About…’
    • ID Your Gene
    • Clinical Trials
    • Resources
    • Rare Retinal Disease Glossary
    • Family Connections
    • Hope in Focus Ambassadors
  • Stories
    • Posts & Videos
    • Photo Gallery
  • Events
    • LCA Family Conference 2023
    • ‘Let’s Chat About…’
    • Dinner in the Dark
  • Contact
    • Get in Touch
    • Email & Newsletter Sign Up
    • Family Connections
  • DONATE
    Leber Congenital Amaurosis Leber Congenital Amaurosis Leber Congenital Amaurosis Leber Congenital Amaurosis
    • About
      • Our Story
      • Our Vision/Mission
      • Our Team
      • Pressroom
    • For Families
      • What is LCA?
      • ‘Let’s Chat About…’
      • ID Your Gene
      • Clinical Trials
      • Resources
      • Rare Retinal Disease Glossary
      • Family Connections
      • Hope in Focus Ambassadors
    • Stories
      • Posts & Videos
      • Photo Gallery
    • Events
      • LCA Family Conference 2023
      • ‘Let’s Chat About…’
      • Dinner in the Dark
    • Contact
      • Get in Touch
      • Email & Newsletter Sign Up
      • Family Connections
    • DONATE

    Archives

    Monthly Archive for: "March, 2022"
    0
    By Rosanne Smyle
    In Blog
    Posted March 29, 2022

    Let’s Chat About … Self-Advocacy and Supporting Your Child’s Education with Beth Borysewicz

    Children living with visual impairment become more independent and empowered when parents set high expectations for their kids and challenge them every day. Just ask Beth Borysewicz. In her role [...]

    READ MORE
    0
    By Rosanne Smyle
    In Blog
    Posted March 9, 2022

    Mother of Toddler Living with LCA6 RPGRIP1 Collaborates with Biotech Odylia to Help Advance Gene Therapy Research

    After crazy months of looking for answers to questions about her infant’s vision, Melissa Matias learned her baby girl, Dylan, had a form of Leber congenital amaurosis known as LCA6 caused […]

    READ MORE
    0
    By Rosanne Smyle
    In Blog
    Posted March 1, 2022

    LCA10 CEP290 Illuminate Clinical Trial Produces No Observed Benefit

    ProQR Therapeutics’ clinical trials of sepofarsen to treat a form of Leber congenital amaurosis (LCA) caused by a mutation in the CEP290 gene did not meet its primary endpoint of […]

    READ MORE
    Sign Up for Our Newsletter
    NEWSLETTER SIGN UP
    Get In Touch
    • 860-266-6062
    • info@hopeinfocus.org
    Follow Us
    Hope in Focus is a 501(C)(3). © All rights reserved.
    Please read our Privacy Promise.
    Skip to content
    Open toolbar Accessibility Tools

    Accessibility Tools

    • Increase TextIncrease Text
    • Decrease TextDecrease Text
    • GrayscaleGrayscale
    • High ContrastHigh Contrast
    • Negative ContrastNegative Contrast
    • Light BackgroundLight Background
    • Links UnderlineLinks Underline
    • Readable FontReadable Font
    • Reset Reset